55824-13-0 Usage
Uses
Used in Pharmaceutical Industry:
5-heptyl-2-((1R,6R)-3-methyl-6-(prop-1-en-2-yl)cyclohex-2-enyl)benzene-1,3-diol is used as a pharmaceutical agent for its potential therapeutic effects. 5-heptyl-2-((1R,6R)-3-methyl-6-(prop-1-en-2-yl)cyclohex-2-enyl)benzene-1,3-diol's unique structure may allow it to interact with biological targets, such as enzymes or receptors, modulating their activity and contributing to the treatment of various diseases.
Used in Cosmetics Industry:
In the cosmetics industry, 5-heptyl-2-((1R,6R)-3-methyl-6-(prop-1-en-2-yl)cyclohex-2-enyl)benzene-1,3-diol is used as an active ingredient for its potential skin benefits. 5-heptyl-2-((1R,6R)-3-methyl-6-(prop-1-en-2-yl)cyclohex-2-enyl)benzene-1,3-diol's hydroxyl and heptyl groups may contribute to moisturization and skin conditioning, improving the overall appearance and health of the skin.
Used in Agrochemical Industry:
5-heptyl-2-((1R,6R)-3-methyl-6-(prop-1-en-2-yl)cyclohex-2-enyl)benzene-1,3-diol is used as an agrochemical agent for its potential applications in crop protection and enhancement. 5-heptyl-2-((1R,6R)-3-methyl-6-(prop-1-en-2-yl)cyclohex-2-enyl)benzene-1,3-diol's complex structure may allow it to act as a pesticide, herbicide, or growth regulator, contributing to improved crop yields and protection against pests and diseases.
Used in Material Science:
In the field of material science, 5-heptyl-2-((1R,6R)-3-methyl-6-(prop-1-en-2-yl)cyclohex-2-enyl)benzene-1,3-diol is used as a component in the development of novel materials. 5-heptyl-2-((1R,6R)-3-methyl-6-(prop-1-en-2-yl)cyclohex-2-enyl)benzene-1,3-diol's unique structure and properties may contribute to the creation of advanced materials with specific characteristics, such as improved mechanical strength, thermal stability, or electrical conductivity.
Used in Research and Development:
5-heptyl-2-((1R,6R)-3-methyl-6-(prop-1-en-2-yl)cyclohex-2-enyl)benzene-1,3-diol is used as a research compound for the study of its chemical properties and potential applications. 5-heptyl-2-((1R,6R)-3-methyl-6-(prop-1-en-2-yl)cyclohex-2-enyl)benzene-1,3-diol's complex structure provides a basis for investigating its reactivity, stability, and interactions with other molecules, contributing to the advancement of scientific knowledge and the development of new technologies.
Check Digit Verification of cas no
The CAS Registry Mumber 55824-13-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,5,8,2 and 4 respectively; the second part has 2 digits, 1 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 55824-13:
(7*5)+(6*5)+(5*8)+(4*2)+(3*4)+(2*1)+(1*3)=130
130 % 10 = 0
So 55824-13-0 is a valid CAS Registry Number.
55824-13-0Relevant articles and documents
CATALYTIC CANNABINOID PROCESSES AND PRECURSORS
-
Page/Page column 35-36, (2020/12/07)
The present disclosure relates to new cannabinoid sulfonate esters and processes for their use to prepare cannabinoids. The disclosure also relates to the use of catalysts and catalytic processes for the preparation of cannabinoids from the cannabinoid sulfonate esters.
C1′-cycloalkyl side chain pharmacophore in tetrahydrocannabinols
Papahatjis, Demetris P.,Nahmias, Victoria R.,Nikas, Spyros P.,Andreou, Thanos,Alapafuja, Shakiru O.,Tsotinis, Andrew,Guo, Jianxin,Fan, Pusheng,Makriyannis, Alexandros
, p. 4048 - 4060 (2008/02/09)
In earlier work we have provided evidence for the presence of a subsite within the CB1 and CB2 cannabinoid receptor binding domains of classical cannabinoids. This putative subsite corresponds to substituents on the C1-position of the C3-alkyl side chain, a key pharmacophoric feature in this class of compounds. We have now refined this work through the synthesis of additional C1′-cycloalkyl compounds using newly developed approaches. Our findings indicate that the C1′-cyclopropyl and C1′-cyclopentyl groups are optimal pharmacophores for both receptors while the C1′-cyclobutyl group interacts optimally with CB1 but not with CB2. The C1′-cyclohexyl analogs have reduced affinities for both CB1 and CB2. However, these affinities are significantly improved with the introduction of a C2′-C3′ cis double bond that modifies the available conformational space within the side chain and allows for a better accommodation of a six-membered ring within the side chain subsite. Our SAR results are highlighted by molecular modeling of key analogs.